Allied Market Research today announced the most comprehensive and strategically analyzed report titled "Stem Cell Umbilical Cord Blood (UCB) Market (Storage Services, Therapeutics, Applications and Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 - 2020"
Portland, OR -- (SBWIRE) -- 04/17/2014 -- Allied Market Research today announced the most comprehensive and strategically analyzed report titled "Stem Cell Umbilical Cord Blood (UCB) Market (Storage Services, Therapeutics, Applications and Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 - 2020" The study observed that the global umbilical cord blood stem cell market is forecasted to reach market value over $11.5 billion in 2014 from $ 6.5billion in 2012.Developments and approvals for novel cord blood stem cells therapies is expected to drive the market growth. The market is expected to reach revenue of $56.4 billion by 2020, growing at CAGR of 33.4%during 2013 to 2020.The storage service market was valued at $7.4billion in 2013.
Browse 67 tables and in-depth TOC on Stem Cell Umbilical Cord Blood (UCB) Market http://www.alliedmarketresearch.com/stem-cell-umbilical-cord-blood-UCB-market
"Cord blood stem cell application is increasing at faster rate than other stem cell techniques because of its efficient and cost effective treatment process. Cord blood is assisting thehealthcare industry to discover novel therapies on chronic diseases. UCB stem cell market is evidencing significant growth due to increasing public awareness and government support."state Allied Market Research analyst Debbie Shields and Roshan Deshmukh.
Increase in prevalence rate of chronic diseases such as cancer, diabetes, blood disease, immune disease, metabolic disease etc. has increased the need of cost effective and efficient way of treatment. However, cord blood stem cells have the potential to treat these chronic diseases effectively. These stem cells have special property of higher cell count in lower blood volume. Collection of these stem cells is much easier than other stem cells and could be stored in specialized preservation facilities called as Cord Blood Stem Cell Banks.
Cord blood stem cells market is in its emerging phase. Significant applications of stem cells in the treatment of various disorders will be commercialized very soon as most of them are in the last phase of clinical trials. Patents for collection techniques and therapeutics methods are approved by respective government of developed countries however patents for UCB stem cells are comparatively less in developing economies.
Biomarkers Market http://www.alliedmarketresearch.com/biomarkers-market
In Vitro Diagnostics (IVD) Market http://www.alliedmarketresearch.com/in-vitro-diagnostic-ivd-market
According to lead analyst Debbie Shields, the geographicanalysis shows that the North American market for cord blood stem cell would account for approx. 44% of total revenue generated by the cord blood market in 2013. However, much expected growth is to occur in Asia-Pacific regions during the forecast period, because of growing demand for chronic disease treatments and widely increasing awareness levels. This report study offers updated review about major market players present in this market such as researcher based pharmaceutical companies and therapeutics services companies.Company profiles in this report include - Advanced Cell Technology Inc., California Stem Cell Inc., Cytori Therapeutics Inc., Mesoblast Limited, Opexa Therapeutics Inc.(USA), Athersys Inc., Geron Corporation, and Neostem Inc.
About Allied Market Research
Allied Market Research (AMR) is a global market research and business consulting wing of Allied Analytics LLP, based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies, and this helps us in digging out market data that helps us generate accurate research data tables and confirm utmost accuracy in our market forecasting. All the data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of concerned domain. Our secondary data procurement methodology includes deep online and offline research and discussions with knowledgeable professionals and analysts in the industry.
5320 SW Macadam Avenue,
Suite 100, Portland, OR 97239
Int’l: +1(617) 674-4143
Toll Free: (855)711-1555 (U.S. & Canada)